Insider sale
ARROWHEAD PHARMACEUTICALS, INC.
$2.51M
39.73K shares
What this filing means
HAMILTON JAMES C plans to sell 39.73K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $2.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001628280-26-000582
Other
Since Oct 2020
39.73K
Shares to sell
$2.51M
Approx. market value
290K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Compensation
Compensation
1/4/2025
100KCompensation
Compensation
1/4/2024
75KCompensation
Compensation
1/4/2023
60KCompensation
Compensation
1/1/2022
55KTotal acquired290K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2025 | Compensation Compensation | 100K | — |
1/4/2024 | Compensation Compensation | 75K | — |
1/4/2023 | Compensation Compensation | 60K | — |
1/1/2022 | Compensation Compensation | 55K | — |
| Total | 290K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
39.73K
Market value
$2.51M
1/5/2026
Total
Units
39.73K
Value
$2.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/5/2026 | 39.73K | $2.51M | NASDAQ | Planned |
| Total | 39.73K | $2.51M | ||